Emami
- Market cap
- ₹ 16,334 Cr.
- P/E
- 21.5x
- P/B
- 5.63x
- 52-week range
- 361.15 – 556.15
- ROE
- 26%
- ROCE
- 28%
- Dividend yield
- 2.7%
- Debt / equity
- 0.06
- Sector
- Personal Products
- Industry
- Personal Care
- Listed on
- NSE, BSE
About
Emami Limited is an India-based company, which is engaged in the manufacture and selling of consumer goods, such as hair care products, healthcare products, and skin care products. The Company’s portfolio of household brand names such as Boro Plus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm, Dermicool and others. Its products include 7 Oils in One Hair Oil Range, Navratna Oil Range, Creme 21 Range, Smart And Handsome Range, BoroPlus Range, Kesh King Range, Pain Management Range, and Emami Gold Range. The Company has a presence of 70 plus countries. The Company’s brands include Discover its personal care and healthcare brands. Its brands include BoroPlus, Navratna, Zandu, Kesh King, Smart And Handsome, Mentho Plus, 7 Oils in One, Dermicool, Creme 21, HE, The Man Company, and Brillare. Its other brands include Emami Malai Kesar Cold Cream, Emami Golden Beauty Talc, Emami Naturally Fair, and Emami Diamond Shine.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Personal Care: 22 companies →Emami against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)21.5 against a typical 33.9: cheaper than most peers (1st = cheapest).7th of 22
- Sales growth+14.9% against a typical +14.9% from a year earlier.8th of 15
- Profit growth−15.2% against a typical +8.9% from a year earlier.10th of 13
- Share price, 3 months−8.8% against a typical −7.5%.12th of 19
- Size₹ 16,333.8 Cr. market value against a typical ₹ 188.1 Cr. (1st = largest).4th of 19
Latest announcements
Exchange filings and their impact on the company.
- Emami closed its share buyback on 9 Oct 2026, a small EPS-accretive cash return with no operational impact.
Emami Limited informed the exchange that its share buyback closed with effect from October 9, 2026. The extracted filing contained no size or price details, only the closure intimation. Completion means bought-back shares will be extinguished, returning cash to shareholders and modestly lifting EPS with no change to operations.
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
No up-to-date rating
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CARE | Withdrawn | Stable | 17 Dec 2025 |
Every agency has withdrawn its rating.
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 17 Dec 2025 | Withdrawn | was CARE AA+ / CARE A1+ | — | CARE | ₹ 168 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 5 Nov 2026Upcoming | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended September 30, 2026, dividend and other business matters |
| 17 Sep 2026 | Buyback/Other business matters | To consider buyback for equity shares and other business matters |
| 4 Aug 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters |
| 21 May 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2026 and other business matters |
| 4 Feb 2026 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended December 31, 2025, dividend and other business matters |
| 10 Nov 2025 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended September 30, 2025, dividend and other business matters |
| 31 Jul 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 865 | 996 | 891 | 906 | 891 | 1,049 | 963 | 904 | 799 | 1,152 | 925 | 1,039 |
| Expenses | 632 | 682 | 682 | 692 | 645 | 715 | 744 | 692 | 622 | 768 | 739 | 815 |
| Operating Profit | 233 | 314 | 209 | 214 | 246 | 334 | 219 | 212 | 177 | 384 | 186 | 225 |
| OPM % | 27% | 32% | 24% | 24% | 28% | 32% | 23% | 23% | 22% | 33% | 20% | 22% |
| Other Income | 11 | 11 | 11 | 10 | 22 | 15 | 21 | 22 | 21 | 9 | 23 | 18 |
| Interest | 2 | 3 | 3 | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 3 | 6 |
| Depreciation | 46 | 46 | 48 | 44 | 45 | 46 | 44 | 44 | 45 | 45 | 42 | 43 |
| Profit before tax | 196 | 276 | 169 | 178 | 220 | 301 | 194 | 187 | 150 | 345 | 164 | 195 |
| Tax % | 8% | 6% | 13% | 16% | 4% | 7% | 16% | 12% | 1% | 7% | 13% | 29% |
| Net Profit | 180 | 261 | 147 | 151 | 211 | 279 | 162 | 164 | 148 | 319 | 143 | 139 |
| EPS in Rs | 4.09 | 5.92 | 3.41 | 3.5 | 4.87 | 6.39 | 3.72 | 3.76 | 3.4 | 7.32 | 3.28 | 3.15 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 5%
- 5 Years
- 6%
- 3 Years
- 4%
- TTM
- 3%
- 10 Years
- 6%
- 5 Years
- 11%
- 3 Years
- 5%
- TTM
- −7%
- 10 Years
- −4%
- 5 Years
- −7%
- 3 Years
- −9%
- TTM
- —
- 10 Years
- 26%
- 5 Years
- 31%
- 3 Years
- 28%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Emami | ₹ 372.00 | ₹ 16,334 Cr. | 21.5x | 5.6x | 26% | — |
| Hindustan Unilever | ₹ 1,820.00 | ₹ 4,27,626 Cr. | 48.3x | 10.3x | 21.5% | 16.1% |
| Godrej Consumer Products | ₹ 851.50 | ₹ 87,134 Cr. | 54.2x | 8.7x | 15.1% | 12.3% |
| Marico | ₹ 764.10 | ₹ 99,347 Cr. | 62.2x | 26x | 43.1% | 13.3% |
| Dabur India | ₹ 366.00 | ₹ 64,927 Cr. | 40x | 6.6x | 17.1% | 14.2% |
| Cupid | ₹ 306.50 | ₹ 41,214 Cr. | 271.9x | 64.1x | 27.3% | 30.3% |
Management
- Radhe Shyam Agarwal
- Chairman Emeritus and Non-Executive Director, Founder
- Radhe Shyam Goenka
- Non-Executive Chairman of the Board, Founder
- Harsha Vardhan Agarwal
- Executive Vice Chairman of the Board, Managing Director
- Mohan Goenka
- Vice Chairman of the Board, Whole Time Director
- Naresh Hiralal Bhansali
- Chief Financial Officer, Chief Executive Officer - Finance, Strategy and Business Development
- Prashant Goenka
- Whole-Time Director
- Sushil Kumar Goenka
- Whole-Time Director
- Priti A. Sureka
- Whole-Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.